LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Average Recommendation of “Hold” from Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST) has earned a consensus rating of “Hold” from the six analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $8.25.

A number of equities analysts have recently issued reports on LFST shares. Barclays cut their price objective on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research report on Friday, August 9th. UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th.

LifeStance Health Group Price Performance

Shares of LFST opened at $5.78 on Thursday. The firm has a market cap of $2.21 billion, a PE ratio of -12.04 and a beta of 1.20. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.20. The business’s 50 day moving average price is $5.41 and its two-hundred day moving average price is $6.06. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $312.30 million for the quarter, compared to the consensus estimate of $305.85 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. LifeStance Health Group’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.13) EPS. On average, equities analysts anticipate that LifeStance Health Group will post -0.25 EPS for the current year.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the business’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the sale, the insider now directly owns 41,932,358 shares of the company’s stock, valued at approximately $246,981,588.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other LifeStance Health Group news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the transaction, the insider now directly owns 41,932,358 shares in the company, valued at approximately $246,981,588.62. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Danish J. Qureshi sold 150,000 shares of LifeStance Health Group stock in a transaction on Friday, June 14th. The stock was sold at an average price of $5.21, for a total transaction of $781,500.00. Following the transaction, the insider now directly owns 439,002 shares in the company, valued at $2,287,200.42. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,037,438 shares of company stock valued at $23,647,876. 6.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On LifeStance Health Group

Several hedge funds have recently modified their holdings of LFST. Vanguard Group Inc. boosted its position in LifeStance Health Group by 1.3% in the first quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock worth $47,318,000 after purchasing an additional 95,197 shares during the last quarter. Brown Advisory Inc. grew its position in LifeStance Health Group by 25.9% during the fourth quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock valued at $40,395,000 after buying an additional 1,062,887 shares during the period. Principal Financial Group Inc. increased its holdings in LifeStance Health Group by 2.8% during the fourth quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after buying an additional 110,457 shares during the last quarter. Jennison Associates LLC raised its position in LifeStance Health Group by 0.7% in the first quarter. Jennison Associates LLC now owns 1,938,323 shares of the company’s stock worth $11,959,000 after acquiring an additional 12,629 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in LifeStance Health Group by 82.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock worth $4,991,000 after acquiring an additional 457,930 shares during the period. Institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.